Company Encyclopedia
View More
name
Cara Therap
CARA.US
Cara Therapeutics, Inc. operates as a biopharmaceutical company that focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company’s lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica.
4.514 T
CARA.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
E
PharmaceuticalsIndustry
Industry Ranking184/184
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-270.01%E
    • Profit Margin-992.95%E
    • Gross Margin-409.85%E
  • Growth ScoreE
    • Revenue YoY-65.96%E
    • Net Profit YoY40.20%B
    • Total Assets YoY-65.17%E
    • Net Assets YoY-108.05%E
  • Cash ScoreE
    • Cash Flow Margin-10.07%D
    • OCF YoY-65.96%E
  • Operating ScoreE
    • Turnover0.08E
  • Debt ScoreE
    • Gearing Ratio110.48%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BUZZ-Cara Therapeutics rises after announcement of reverse stock split

    Shares of biopharma firm Cara Therapeuticsrise 14.5% to $5.61Cara says that its board has approved a 1-for-3 reverse stock split, effective April 15Cara entered into a merger agreement with privately held Tvardi Therapeutics in DecemberThe stock split will be under the new name Tvardi Therapeutics Inc and symbol “TVRD” after the anticipated closing of the mergerAfter the closing of the merger, the combined company’s total outstanding shares are expected to be about 9.4 millionAs of last close, CARA had fallen 14.2% YTD

    Reuters·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%
    Reuters·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%

    Cara Therapeutics initiates 1-for-3 reverse stock split amid merger with Tvardi Therapeutics, effective per Board approval.

    In Stamford, Connecticut on April 14, 2025, Cara Therapeutics, Inc. disclosed a major decision. The company, listed as CARA on Nasdaq, revealed that its Board of Directors has greenlit a 1-for-3 reverse stock split for its current common stock shares.

    Unusual Whales·
    US
    CARA
    0.00%
    Unusual Whales·
    US
    CARA
    0.00%

    Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics

    Cara Therapeutics has announced a 1-for-3 reverse stock split of its common stock in connection with its proposed merger with Tvardi Therapeutics. The reverse stock split will take effect on April 15, 2025, reducing the number of outstanding shares from approximately 4.6 million to about 1.5 million. Following the merger, the combined company will have around 9.4 million shares outstanding. The new company will operate under the name Tvardi Therapeutics, Inc. and the symbol "TVRD."

    GlobeNewswire·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%
    GlobeNewswire·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%

    Cannabis Stock Movers For April 3, 2025

    Cann Group CNGGF shares closed up 217.50% at $0.02 1933 Industries TGIFF shares closed up 47.06% at $0.01 iAnthus Capital Hldgs ITHUF shares closed up 29.82% at $0.01 Nextleaf Solutions OILFF shares closed up 8.38% at $0.04 Cara Therapeutics CARA shares closed up 7.45% at $4.95

    Benzinga·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%
    Benzinga·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%

    Cannabis Stock Movers For April 2, 2025

    Global Hemp Group GBHPF shares closed up 215.32% at $0.04 Leafbuyer Techs LBUY shares closed up 25.00% at $0.03 Kaya Holdings KAYS shares closed up 11.41% at $0.04 Cara Therapeutics CARA shares closed up 10.93% at $5.10 SOL Glb Inv SOLCF shares closed up 9.39% at $0.05

    Benzinga·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%
    Benzinga·
    US
    CARA
    0.00%
    US
    TVRD
    +1.46%
    © 2025 Longbridge｜Disclaimer